Top Markets
Coin of the day
Raphael Pharmaceutical Inc. Raphael Pharmaceutical Inc.

Raphael Pharmaceutical Inc.

RAPH
Rangering i aksjer #28150
Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating... Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating its efforts on discovering and clinically developing novel therapeutic solutions. These treatments primarily leverage cannabinoids and are designed to enhance patients' quality of life. Currently, the company's leading investigational drug candidate is being advanced for the management of rheumatoid arthritis. Furthermore, Raphael Pharma plans to broaden its pipeline to include more cannabinoid-based medicines aimed at various cancer types and other autoimmune conditions. The company's corporate headquarters are situated in Tel Aviv-Jaffa, Israel.
Aksjekurs
$1.40
Sist synkronisert: 2026-08-18
Markedsverdi
$28.25M
Endring (1 dag)
0.00%
Endring (1 år)
536.36%
Land
IL
Handel Raphael Pharmaceutical Inc. (RAPH)

Kategori

Utbytteavkastning for Raphael Pharmaceutical Inc. (RAPH)
Raphael Pharmaceutical Inc. (aksjesymbol: RAPH) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Raphael Pharmaceutical Inc. (RAPH) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter